During the past decade, Paragon Rx Clinical conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 18 clinical trials were completed, i.e. on average, 85.7% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 11 clinical trials were completed. i.e. 68.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Paragon Rx Clinical" #1 sponsor was "Phathom Pharmaceuticals, Inc." with 4 trials, followed by "Exact Sciences Corporation" with 3 trials sponsored, "Ironwood Pharmaceuticals, Inc." with 3 trials sponsored, "BioDelivery Sciences International" with 2 trials sponsored and "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Paragon Rx Clinical" #1 collaborator was "Allergan Sales, LLC" with 2 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Bright Research Center" with 1 trials as a collaborator, "EDP Biotech" with 1 trials as a collaborator and "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Paragon Rx Clinical" are "Colorectal Cancer" (6 trials), "Low Back Pain" (3 trials), "Diabetic Gastroparesis" (2 trials), "Heartburn" (2 trials) and "Hepatitis B, Chronic" (2 trials). Many other conditions were trialed in "Paragon Rx Clinical" in a lesser frequency.

Most popular intervention types in "Paragon Rx Clinical" are "Drug" (21 trials), "Diagnostic Test" (4 trials), "Biological" (3 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Vonoprazan" (4 trials), "Lansoprazole" (2 trials), "Oseltamivir" (2 trials) and "Afluria® Quadrivalent" (1 trials). Other intervention names were less common.

The vast majority of trials in "Paragon Rx Clinical" are 30 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Paragon Rx Clinical". undefined are not yet recruiting, 3 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Paragon Rx Clinical, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Paragon Rx Clinical, 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".